Investigational therapy through a clinical trial may be an option for your child as initial therapy or if standard treatments are not effective enough to cure the cancer. One investigational approach is called radioimmunotherapy. In this method, a protein called an antibody ferries radiation directly to DSRCT cells without harming normal cells. The MSK Kids team is hopeful that other research projects will result in more effective standard therapies for DSRCTs and help more children with this rare tumor to live longer.

Your child’s care team will let you know if your child can participate in a clinical trial. The decision to enroll is entirely voluntary. The study team will explain the benefits and risks of the study to you so you can make an informed decision.